Header Logo

Connection

Amarjit Virdi to Bone Morphogenetic Proteins

This is a "connection" page, showing publications Amarjit Virdi has written about Bone Morphogenetic Proteins.
Connection Strength

1.263
  1. Sclerostin antibody treatment improves implant fixation in a model of severe osteoporosis. J Bone Joint Surg Am. 2015 Jan 21; 97(2):133-40.
    View in: PubMed
    Score: 0.464
  2. Modulation of VEGF expression in rat bone marrow stromal cells by GDF-5. Connect Tissue Res. 2007; 48(6):324-31.
    View in: PubMed
    Score: 0.266
  3. Phenotypic and molecular heterogeneity in fibrodysplasia ossificans progressiva. Calcif Tissue Int. 1999 Sep; 65(3):250-5.
    View in: PubMed
    Score: 0.160
  4. Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines. Cell Mol Biol (Noisy-le-grand). 1998 Dec; 44(8):1237-46.
    View in: PubMed
    Score: 0.152
  5. Sclerostin antibody prevents particle-induced implant loosening by stimulating bone formation and inhibiting bone resorption in a rat model. Arthritis Rheum. 2012 Dec; 64(12):4012-20.
    View in: PubMed
    Score: 0.100
  6. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model. J Bone Joint Surg Am. 2006 Apr; 88(4):806-17.
    View in: PubMed
    Score: 0.063
  7. Effect of low intensity pulsed ultrasound and BMP-2 on rat bone marrow stromal cell gene expression. J Orthop Res. 2005 May; 23(3):646-52.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.